BRIEF published on 10/09/2025 at 17:35, 1 month 26 days ago Biotest's Yimmugo® Enters the U.S. Market Biotest AG U.S. Market Yimmugo® Launch Primary Immunodeficiencies Plasma-derived Medicines
PRESS RELEASE published on 10/09/2025 at 17:30, 1 month 26 days ago Biotest’s Yimmugo® launches in the United States Biotest AG launches Yimmugo®, a polyvalent human normal immunoglobulin (IVIg) for primary immunodeficiencies in the U.S., marking a significant milestone for the company's global growth strategy Biotest AG Yimmugo U.S. Launch Primary Immunodeficiencies IVIg
BRIEF published on 09/19/2025 at 15:05, 2 months 15 days ago Biotest AG organise une assemblée générale extraordinaire pour modifier sa forme juridique Assemblée Générale Extraordinaire Grifols SA Société En Commandite Par Actions Biotest AG Changement De Forme Juridique
BRIEF published on 09/19/2025 at 15:05, 2 months 15 days ago Biotest AG Schedules Extraordinary General Meeting for Legal Form Change Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Change Partnership Limited By Shares
PRESS RELEASE published on 09/19/2025 at 15:00, 2 months 15 days ago Biotest AG: Extraordinary general meeting convened at the request of Grifols S.A. Biotest AG's extraordinary general meeting convened at the request of Grifols S.A. to discuss changing legal form to a partnership limited by shares (KGaA) on 28 October 2025 Extraordinary General Meeting Biotest AG Legal Form Change Grifols Partnership Limited By Shares
BRIEF published on 08/04/2025 at 13:05, 4 months ago Biotest AG Under Review for Legal Structure Change Grifols S.A. Shareholder Rights Biotest AG Extraordinary Meeting Legal Structure
BRIEF published on 08/04/2025 at 13:05, 4 months ago Biotest AG fait l'objet d'un examen pour un changement de structure juridique Grifols SA Biotest AG Droits Des Actionnaires Structure Juridique Réunion Extraordinaire
PRESS RELEASE published on 08/04/2025 at 13:00, 4 months ago Biotest AG receives a request from Grifols S.A. to convene an extraordinary general meeting Biotest AG receives a request from Grifols S.A. to convene an extraordinary general meeting for proposed conversion into Biotest GmbH & Co. KGaA Shareholders Grifols S.A. Extraordinary General Meeting Biotest AG Legal Form Conversion
BRIEF published on 07/02/2025 at 18:13, 5 months 2 days ago Biotest AG's Annual Meeting Approves Dividend Distribution Annual General Meeting Shareholder Approval Dividend Distribution Biotest AG Grifols Group
BRIEF published on 07/02/2025 at 18:13, 5 months 2 days ago L'assemblée annuelle de Biotest AG approuve la distribution de dividendes Biotest AG Assemblée Générale Annuelle Approbation Des Actionnaires Distribution De Dividendes Groupe Grifols
Published on 12/05/2025 at 02:35, 5 hours 35 minutes ago Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 01:00, 7 hours 10 minutes ago BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 9 hours 5 minutes ago BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 9 hours 10 minutes ago NXT Energy Solutions Completes Data Acquisition for SFD Survey
Published on 12/05/2025 at 08:01, 9 minutes ago Original-Research: Warimpex Finanz- und Beteiligungsholding AG (von East Value Research GmbH ):
Published on 12/05/2025 at 08:00, 10 minutes ago Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) approaches the 500-million mark ahead of listing
Published on 12/05/2025 at 07:00, 1 hour 10 minutes ago Swiss Re targets a net income of USD 4.5 billion in 2026; refreshed strategy to strengthen core business
Published on 12/05/2025 at 03:30, 4 hours 40 minutes ago CGTN: What makes cooperation between China and France a two-way success
Published on 12/04/2025 at 23:50, 8 hours 19 minutes ago EQS-Adhoc: Dexus Finance Pty Limited: Dexus prices A$500 million of subordinated notes
Published on 12/04/2025 at 18:14, 13 hours 56 minutes ago Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025
Published on 12/04/2025 at 18:00, 14 hours 10 minutes ago Information concerning the total number of voting rights and shares in the share capital as of November 28, 2025
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago Informations relatives au nombre total de droits de vote et d’actions
Published on 12/04/2025 at 17:45, 14 hours 25 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
